Malwarebytes Acquires Cyrus

Malwarebytes Acquires AzireVPN

November 7, 2024

Cybersecurity

Malwarebytes has acquired AzireVPN, a privacy-focused VPN provider, to strengthen its consumer privacy and VPN capabilities. The deal will allow Malwarebytes to integrate AzireVPN's VPN technologies (including the Blind Operator feature) into its security and privacy product portfolio; terms were not disclosed.

Cycode Acquires Bearer

March 5, 2024

Cybersecurity

Application security platform Cycode has acquired Bearer, a SAST startup that also provides API discovery and data-leak protection, to integrate Bearer’s AI-powered static analysis and remediation capabilities into its Application Security Posture Management (ASPM) platform. Financial terms were not disclosed; Cycode will migrate Bearer customers onto its platform over time and use Bearer’s engine and AI assistant to deepen scanning, precision, and remediation workflows.

CyberMaxx Acquires CipherTechs

February 28, 2023

Cybersecurity

Periscope Equity portfolio company CyberMaxx has acquired CipherTechs to expand its suite of cybersecurity services, combining offensive, defensive, DFIR, and GRC capabilities. CyberMaxx also announced the appointment of Brian Ahern as CEO as the combined business targets broader growth across regulated industries.

Vector Capital Makes $100M Minority Investment in Malwarebytes

September 21, 2022

Cybersecurity

Vector Capital will make a strategic $100 million minority growth investment in Malwarebytes to accelerate product innovation, expand its channel and MSP programs, and consolidate ownership. As part of the deal, two Vector Managing Directors will join Malwarebytes' board; the transaction is expected to close in Q4 2022.

Cyrus Biotechnology Acquires Orthogonal Biologics and Raises $18M Series B

December 6, 2021

Biotechnology

Cyrus Biotechnology completed an acquisition of Orthogonal Biologics and closed an $18 million Series B financing to build an integrated software-and-screening pre-clinical biologics discovery firm. The financing was led by a syndicate including OrbiMed Advisors, Trinity Ventures, Agent Capital and other investors, with Selecta Bioscience joining as a strategic investor; the acquisition brings Orthogonal’s deep mutational scanning protein engineering capabilities into Cyrus’s computational discovery platform.

Mastercard Acquires CipherTrace

September 9, 2021

Payments & Fintech

Mastercard has acquired CipherTrace, a cryptocurrency intelligence company, to strengthen its digital assets security, fraud detection and compliance capabilities. The deal integrates CipherTrace’s blockchain analytics and intelligence with Mastercard’s AI, cyber and payments infrastructure to provide greater transparency and regulatory support for customers; terms were not disclosed.